化学
推论
计算机科学
人工智能
机器学习
数量结构-活动关系
药物靶点
训练集
药物发现
任务(项目管理)
人工神经网络
适用范围
集合(抽象数据类型)
深度学习
生物信息学
化学
生物
经济
生物化学
管理
程序设计语言
作者
Emma Svensson,Pieter-Jan Hoedt,Sepp Hochreiter,Günter Klambauer
标识
DOI:10.1021/acs.jcim.3c01417
摘要
A central problem in drug discovery is to identify the interactions between drug-like compounds and protein targets. Over the past few decades, various quantitative structure–activity relationship (QSAR) and proteo-chemometric (PCM) approaches have been developed to model and predict these interactions. While QSAR approaches solely utilize representations of the drug compound, PCM methods incorporate both representations of the protein target and the drug compound, enabling them to achieve above-chance predictive accuracy on previously unseen protein targets. Both QSAR and PCM approaches have recently been improved by machine learning and deep neural networks, that allow the development of drug–target interaction prediction models from measurement data. However, deep neural networks typically require large amounts of training data and cannot robustly adapt to new tasks, such as predicting interaction for unseen protein targets at inference time. In this work, we propose to use HyperNetworks to efficiently transfer information between tasks during inference and thus to accurately predict drug–target interactions on unseen protein targets. Our HyperPCM method reaches state-of-the-art performance compared to previous methods on multiple well-known benchmarks, including Davis, DUD-E, and a ChEMBL derived data set, and particularly excels at zero-shot inference involving unseen protein targets. Our method, as well as reproducible data preparation, is available at https://github.com/ml-jku/hyper-dti.
科研通智能强力驱动
Strongly Powered by AbleSci AI